Sreejesh Moolayadukkam

Repurposing Alzheimer’s and ovarian cancer drugs as sonosensitizers for glioblastoma via a positive-unlabeled learning and 3D bioprinting-based new approach methodology (NAM)

A neural network-based positive-unlabeled learning framework with a high-throughput, magnetic field–guided 3D bioprinting platform is introduced that enables rapid repurposing of approved drugs as SDT sensitizers and provides a scalable framework for advancing GBM therapeutic discovery while reducing reliance on animal...